These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36447133)

  • 21. Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant-infected patients in Jiangsu, China.
    Hu Z; Tao B; Li Z; Song Y; Yi C; Li J; Zhu M; Yi Y; Huang P; Wang J
    Int J Infect Dis; 2022 Mar; 116():204-209. PubMed ID: 35065255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characteristics and related factors of viral nucleic acid negative conversion in children infected with Omicron variant strain of SARS-CoV-2].
    Yin R; Lu Q; Jiao JL; Lin K; Wang C; Yuan L; Ding Y; Dong N; Wang BJ; Niu YH; Fang YS; Liu W; Sun YF; Zou B; Zhang XE; Xiao P; Sun L; Du X; Zhu YY; Dong XY
    Zhonghua Er Ke Za Zhi; 2022 Dec; 60(12):1307-1311. PubMed ID: 36444435
    [No Abstract]   [Full Text] [Related]  

  • 23. Chest CT features of children infected by B.1.617.2 (Delta) variant of COVID-19.
    Cheng QR; Fan MX; Hao J; Hu XC; Ge XH; Hu ZL; Li Z
    World J Pediatr; 2022 Jan; 18(1):37-42. PubMed ID: 34811704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection.
    Epaulard O; Abgrall S; Lefebvre M; Faucher JF; Michon J; Frentiu E; Blanchi S; Janssen C; Charbonnier G; Fresse A; Laurent S; Sandjakian L; Casez P; Mahamat A; Beraud G
    Clin Microbiol Infect; 2022 Dec; 28(12):1629-1635. PubMed ID: 35779764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection during the delta (B.1.617.2) variant surge in India: a test-negative, case-control study and a mechanistic study of post-vaccination immune responses.
    Thiruvengadam R; Awasthi A; Medigeshi G; Bhattacharya S; Mani S; Sivasubbu S; Shrivastava T; Samal S; Rathna Murugesan D; Koundinya Desiraju B; Kshetrapal P; Pandey R; Scaria V; Kumar Malik P; Taneja J; Binayke A; Vohra T; Zaheer A; Rathore D; Ahmad Khan N; Shaman H; Ahmed S; Kumar R; Deshpande S; Subramani C; Wadhwa N; Gupta N; Pandey AK; Bhattacharya J; Agrawal A; Vrati S; Bhatnagar S; Garg PK;
    Lancet Infect Dis; 2022 Apr; 22(4):473-482. PubMed ID: 34838183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical features and high resolution CT imaging evolution of coronavirus disease 2019].
    Lu XF; Gong W; Wang L; Li L; Xie BJ; Peng ZF; Zha YF
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):509-515. PubMed ID: 32486557
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and immune response characteristics among vaccinated persons infected with SARS-CoV-2 delta variant: a retrospective study.
    Wang C; Li Y; Pan Y; Zhou L; Zhang X; Wei Y; Guo F; Shu Y; Gao J
    J Zhejiang Univ Sci B; 2022 Nov; 23(11):899-914. PubMed ID: 36379610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. COVID-19 Recovery Patterns Across Alpha (B.1.1.7) and Delta (B.1.617.2) Variants of SARS-CoV-2.
    Kumar N; Quadri S; AlAwadhi AI; AlQahtani M
    Front Immunol; 2022; 13():812606. PubMed ID: 35237265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence from an outbreak in Yunnan, China, 2021.
    Ma C; Sun W; Tang T; Jia M; Liu Y; Wan Y; Han J; Rodewald L; Li J; Song Y; Wang Y; Wu D; Wang F; Zheng H; Tang L; Gao GF; Yin Z; An Z
    Vaccine; 2022 May; 40(20):2869-2874. PubMed ID: 35400561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of COVID-19 Vaccinations With Intensive Care Unit Admissions and Outcome of Critically Ill Patients With COVID-19 Pneumonia in Lombardy, Italy.
    Grasselli G; Zanella A; Carlesso E; Florio G; Canakoglu A; Bellani G; Bottino N; Cabrini L; Castelli GP; Catena E; Cecconi M; Cereda D; Chiumello D; Forastieri A; Foti G; Gemma M; Giudici R; Grazioli L; Lombardo A; Lorini FL; Madotto F; Mantovani A; Mistraletti G; Mojoli F; Mongodi S; Monti G; Muttini S; Piva S; Protti A; Rasulo F; Scandroglio AM; Severgnini P; Storti E; Fumagalli R; Pesenti A;
    JAMA Netw Open; 2022 Oct; 5(10):e2238871. PubMed ID: 36301541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Shedding of infectious SARS-CoV-2 despite vaccination.
    Riemersma KK; Haddock LA; Wilson NA; Minor N; Eickhoff J; Grogan BE; Kita-Yarbro A; Halfmann PJ; Segaloff HE; Kocharian A; Florek KR; Westergaard R; Bateman A; Jeppson GE; Kawaoka Y; O'Connor DH; Friedrich TC; Grande KM
    PLoS Pathog; 2022 Sep; 18(9):e1010876. PubMed ID: 36178969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence.
    Ren HW; Wu Y; Dong JH; An WM; Yan T; Liu Y; Liu CC
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8210-8218. PubMed ID: 32767351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Likelihood of infecting or getting infected with COVID-19 as a function of vaccination status, as investigated with a stochastic model for Aotearoa New Zealand for Delta and Omicron variants.
    Watson LM
    N Z Med J; 2022 Apr; 135():89-100. PubMed ID: 35728188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmission of and Infection With COVID-19 Among Vaccinated and Unvaccinated Attendees of an Indoor Wedding Reception in Minnesota.
    Wienkes H; Vilen K; Lorentz A; Gerlach D; Wang X; Saupe A; Danila R; Lynfield R; Smith K; Medus C
    JAMA Netw Open; 2022 Feb; 5(2):e220536. PubMed ID: 35212747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.
    Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR
    JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.
    Eyre DW; Taylor D; Purver M; Chapman D; Fowler T; Pouwels KB; Walker AS; Peto TEA
    N Engl J Med; 2022 Feb; 386(8):744-756. PubMed ID: 34986294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History.
    Drews SJ; Hu Q; Samson R; Abe KT; Rathod B; Colwill K; Gingras AC; Yi QL; O'Brien SF
    Microbiol Spectr; 2022 Feb; 10(1):e0226221. PubMed ID: 35171006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARS-CoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study.
    Nygaard U; Holm M; Hartling UB; Glenthøj J; Schmidt LS; Nordly SB; Matthesen AT; von Linstow ML; Espenhain L
    Lancet Child Adolesc Health; 2022 Jul; 6(7):459-465. PubMed ID: 35526537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.